XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 38 filers reported holding XENON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,145,623 | -27.4% | 121,359 | -67.5% | 0.76% | +57.6% |
| Q3 2021 | $5,707,000 | -88.9% | 373,510 | +35.3% | 0.48% | -86.2% |
| Q2 2021 | $51,412,000 | +848.2% | 276,130 | -48.3% | 3.48% | +602.4% |
| Q1 2019 | $5,422,000 | +91.2% | 533,655 | +18.7% | 0.50% | +54.7% |
| Q4 2018 | $2,836,000 | -43.4% | 449,484 | +18.4% | 0.32% | -44.3% |
| Q3 2018 | $5,009,000 | +24.0% | 379,484 | -13.6% | 0.58% | +3.2% |
| Q2 2018 | $4,039,000 | +500.1% | 439,034 | +92.5% | 0.56% | +480.2% |
| Q3 2017 | $673,000 | -6.3% | 228,029 | 0.0% | 0.10% | -21.3% |
| Q2 2017 | $718,000 | -45.3% | 228,029 | -30.5% | 0.12% | -52.3% |
| Q1 2017 | $1,312,000 | -48.1% | 328,029 | 0.0% | 0.26% | -59.9% |
| Q4 2016 | $2,526,000 | +36.8% | 328,029 | +43.9% | 0.64% | +112.3% |
| Q3 2016 | $1,847,000 | – | 228,029 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |